Author/Authors :
Mashayekhi, Simin O. tabriz university of medical sciences - Faculty of Pharmacy, National Public health Management Center (NPMC), ايران , Ghandforoush-Sattari, Mohammadreza tabriz university of medical sciences - Faculty of Pharmacy, Hematology and Oncology Research Centre, ايران , Rahimipour, Ali tabriz university of medical sciences - Faculty of Medicine, ايران
Abstract :
To the Editor, Many patients at end stage renal disease (ESRD) suffer from abnormalities of lipid metabolism. These include high level of triglyceride (TG) and low level of high density lipoprotein cholesterol (HDLc), with normal level of total cholesterol (TC) and Low density lipoprotein cholesterol (LDLc).
